AusPAR: Crysvita

Australian Public Assessment Report

AusPAR

AusPAR: Crysvita [PDF, 816.45 KB]

AusPAR: Crysvita [Word, 587.02 KB]

Attachment-Product information for Crysvita [PDF, 357.45 KB]

Attachment-Product information for Crysvita [Word, 304.24 KB]

Device/Product Name

Crysvita

Active ingredients

Burosumab

AusPAR Date

29 June 2022

Published

28 July 2022

Submission Number

PM-2020-03892-1-5

Submission Type

New biological entity

Decision

Approved